Neovasc Announces Publication of Safety and Efficacy Results from REDUCE Study in International Journal of Cardiology
NASDAQ, TSX: NVCN VANCOUVER, Aug. 6, 2018 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, today announced ...